3-{[(4-chlorophenyl)methyl]sulfanyl}-5-phenyl-4H-1,2,4-triazol-4-amine

Catalog No.: 
ACCBGI004
CAS No.: 
860609-05-8
Molecular Formula: 
C15H13ClN4S
Molecular Weight: 
316.82
3-{[(4-chlorophenyl)methyl]sulfanyl}-5-phenyl-4H-1,2,4-triazol-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$170.00InquiryInquiry
1g95%$536.00InquiryInquiry
5g95%$2653.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-{[(4-chlorophenyl)methyl]sulfanyl}-5-phenyl-4H-1,2,4-triazol-4-amine
IUPAC Name3-((4-chlorobenzyl)thio)-5-phenyl-4H-1,2,4-triazol-4-amine
MDL No.MFCD03609810
Molecular FormulaC15H13ClN4S
Molecular Weight316.82
SMILESNN1C(SCC2=CC=C(Cl)C=C2)=NN=C1C3=CC=CC=C3
InChI KeyMXAUMURNNHOUSA-UHFFFAOYSA-N
Synonym3-[(4-chlorobenzyl)sulfanyl]-5-phenyl-4H-1,2,4-triazol-4-ylamine;3-[(4-chlorobenzyl)sulfanyl]-5-phenyl-4H-1,2,4-triazol-4-amine;4H-1,2,4-Triazol-4-amine, 3-[[(4-chlorophenyl)methyl]thio]-5-phenyl-
CAS No.860609-05-8

Synthetic Route by SureRoute

1. ACCBGI004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLZWT302 route compound structure diagram
    ACLZWT30222706-11-2In Stock
  4. Then
  5. ACCBGI004 route product structure diagram
    ACCBGI004860609-05-8
Inquiry

2. ACCBGI004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLZWT302 route compound structure diagram
    ACLZWT30222706-11-2In Stock
  4. Then
  5. ACCBGI004 route product structure diagram
    ACCBGI004860609-05-8
Inquiry

3. ACCBGI004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCBGI004 route product structure diagram
    ACCBGI004860609-05-8
Inquiry

Comments (0)